https://www.selleckchem.com/pr....oducts/Semagacestat(
Crown Copyright © 2020 Published by Elsevier B.V. on behalf of European Society for Radiotherapy Oncology.Background and purpose Retroperitoneal sarcoma (RPS) is a rare, complex disease requiring multidisciplinary management. We have previously reported that use of the Revised Edmonton Symptom Assessment Scale (ESAS-r-CSS) allows for proactive symptom management, and we sought to report the results of ESAS-r-CSS screening during pre-operative radiotherapy (RT) for a cadre of patients with RPS. Materials and methods
Like
Comment
Share
